Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0UXJ2
|
|||
| Drug Name |
Omidubicel
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Hematologic tumour [ICD-11: 2B33.Y] | Phase 3 | [1] | |
| Company |
Gamida Cell
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04260698) Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.